Due to its potential influence on, particularly, tumor vascularization and hypoxia, functional expression of EphB4 should be considered as potential differentiating characteristics or biomarker of malignant melanoma, which preferentially should be determined by non-invasive imaging. The gene discussed is EPHB4; the disease is neoplasm.